SYNT - Ticker AI Digest

Synthomer plc 📰 3
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Synthomer plc in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
SYNT Data 2025-08-05 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (SYNT) 3
SYNT 10:58
Synthomer plc
Director/PDMR Shareholding
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of ordinary shares of 1 pence each in Synthomer plc
SYNT 10:01
Synthomer plc
Directorate Change
SYNT 06:01
Synthomer plc
Interim results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Synthomer PLC Interim Results for H1 2025**
Synthomer PLC, a leading supplier of specialized polymers and ingredients, reported its interim results for the six months ended June 30, 2025, highlighting continued earnings growth despite subdued market conditions. Key points from the report include
### **Financial Performance**
**Revenue**Declined by 9.8% to £925.2 million (H1 2024: £1,025.6 million), with a constant currency decline of 8.8%, primarily due to lower volumes and raw material price pass-throughs.
**EBITDA**Increased by 4.1% to £77.8 million (H1 2024: £74.7 million), with a constant currency growth of 5.4%, driven by self-help actions and cost efficiencies.
**EBITDA Margin**Improved to 8.4% from 7.3% in H1 2024, reflecting better cost management.
**Underlying Operating Profit (EBIT)**Rose slightly by 0.4% to £28.3 million (H1 2024: £28.2 million).
**Statutory Operating Loss (EBIT)**Narrowed to £1.0 million (H1 2024: £2.9 million loss).
**Net Debt**Increased to £638.3 million (H1 2024: £560.6 million) due to seasonal cash flow patterns and capital expenditure.
### **Divisional Performance**
**Coatings & Construction Solutions (CCS)**: Revenue declined by 13.5% to £372.5 million, with EBITDA down 34.9% to £34.5 million, impacted by lower oil and gas drilling activity.
**Adhesive Solutions (AS)**Revenue decreased by 3.3% to £298.4 million, but EBITDA surged by 61.6% to £35.4 million, driven by cost efficiency and reliability improvements.
**Health & Protection and Performance Materials (HPPM)**: Revenue fell by 11.2% to £254.3 million, with EBITDA up 23.0% to £16.6 million, benefiting from favorable mix and cost reductions.
### **Strategic Initiatives**
**Portfolio Transformation**Completed the divestment of William Blythe in May 2025, reducing the global manufacturing footprint to <mark style="background-color:yellow">below</mark> 30 sites (from 43 in 2022).
**Cost Reduction**Implemented a £20-25 million cost reduction program, expected to deliver £9 million in benefits in H2 2025.
**Innovation**Launched new specialty adhesive investments in the US and expanded partnerships for medical glove technology.
### **Market Conditions**
**Tariff Impact**Limited direct exposure to new tariffs, but increased customer demand volatility in Q2, improving in June.
**End-Market Demand**Subdued due to trade tensions, with volumes down 7.1% compared to H1 2024.
### **Outlook**
**2025 Expectations**Some earnings progress and broadly neutral Free Cash Flow, supported by self-help actions and strategic benefits.
**Medium-Term Goal**Aim to double recent earnings levels through self-help, volume recovery, and strategic execution.
### **CEO Commentary**
CEO Michael Willome emphasized the company’s resilience in challenging markets, highlighting the success of self-help actions and strategic portfolio adjustments. He reaffirmed confidence in achieving medium-term earnings growth despite near-term uncertainties.
### **Key Metrics**
**Free Cash Flow**Negative £30.3 million (H1 2024: Negative £31.2 million), with expectations of positive cash flow in H2.
**Net Debt to EBITDA Ratio**Increased to 4.8x (H1 2024: 4.6x), within covenant limits.
Synthomer remains focused on derisking its balance sheet, advancing its specialty strategy, and prioritizing sustainable growth opportunities.
Here is a comparison of Synthomer PLC's financials and debt year on year, presented as an HTML table:
MetricH1 2025H1 2024Change
Revenue (£m)925.21,025.6(9.8%)
EBITDA (£m)77.874.7+4.1%
EBITDA margin (%)8.4%7.3%+110bps
Underlying operating profit (£m)28.328.2+0.4%
Statutory operating loss (£m)(1.0)(2.9)+65.5%
Net debt (£m)638.3560.6+13.9%
Free Cash Flow (£m)(30.3)(31.2)+2.9%

Key Observations:

  • Revenue decreased by 9.8% year-on-year, primarily due to lower volumes and pass-through of lower raw material prices.
  • EBITDA increased by 4.1%, driven by self-help actions, including robust pricing and cost efficiency improvements.
  • Net debt increased by 13.9%, mainly due to seasonal cash flow patterns and capital expenditure phasing.
  • Free Cash Flow improved slightly, with expectations of positive Free Cash Flow in H2 2025.
**Note:** The percentages in the "Change" column are calculated based on the provided data. The table provides a concise comparison of key financial metrics and debt levels between H1 2025 and H1 2024.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
SYNT 10:58
Synthomer plc
Director/PDMR Shareholding
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of ordinary shares of 1 pence each in Synthomer plc
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
SYNT 06:01
Synthomer plc
Interim results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Synthomer PLC Interim Results for H1 2025**
Synthomer PLC, a leading supplier of specialized polymers and ingredients, reported its interim results for the six months ended June 30, 2025, highlighting continued earnings growth despite subdued market conditions. Key points from the report include
### **Financial Performance**
**Revenue**Declined by 9.8% to £925.2 million (H1 2024: £1,025.6 million), with a constant currency decline of 8.8%, primarily due to lower volumes and raw material price pass-throughs.
**EBITDA**Increased by 4.1% to £77.8 million (H1 2024: £74.7 million), with a constant currency growth of 5.4%, driven by self-help actions and cost efficiencies.
**EBITDA Margin**Improved to 8.4% from 7.3% in H1 2024, reflecting better cost management.
**Underlying Operating Profit (EBIT)**Rose slightly by 0.4% to £28.3 million (H1 2024: £28.2 million).
**Statutory Operating Loss (EBIT)**Narrowed to £1.0 million (H1 2024: £2.9 million loss).
**Net Debt**Increased to £638.3 million (H1 2024: £560.6 million) due to seasonal cash flow patterns and capital expenditure.
### **Divisional Performance**
**Coatings & Construction Solutions (CCS)**: Revenue declined by 13.5% to £372.5 million, with EBITDA down 34.9% to £34.5 million, impacted by lower oil and gas drilling activity.
**Adhesive Solutions (AS)**Revenue decreased by 3.3% to £298.4 million, but EBITDA surged by 61.6% to £35.4 million, driven by cost efficiency and reliability improvements.
**Health & Protection and Performance Materials (HPPM)**: Revenue fell by 11.2% to £254.3 million, with EBITDA up 23.0% to £16.6 million, benefiting from favorable mix and cost reductions.
### **Strategic Initiatives**
**Portfolio Transformation**Completed the divestment of William Blythe in May 2025, reducing the global manufacturing footprint to <mark style="background-color:yellow">below</mark> 30 sites (from 43 in 2022).
**Cost Reduction**Implemented a £20-25 million cost reduction program, expected to deliver £9 million in benefits in H2 2025.
**Innovation**Launched new specialty adhesive investments in the US and expanded partnerships for medical glove technology.
### **Market Conditions**
**Tariff Impact**Limited direct exposure to new tariffs, but increased customer demand volatility in Q2, improving in June.
**End-Market Demand**Subdued due to trade tensions, with volumes down 7.1% compared to H1 2024.
### **Outlook**
**2025 Expectations**Some earnings progress and broadly neutral Free Cash Flow, supported by self-help actions and strategic benefits.
**Medium-Term Goal**Aim to double recent earnings levels through self-help, volume recovery, and strategic execution.
### **CEO Commentary**
CEO Michael Willome emphasized the company’s resilience in challenging markets, highlighting the success of self-help actions and strategic portfolio adjustments. He reaffirmed confidence in achieving medium-term earnings growth despite near-term uncertainties.
### **Key Metrics**
**Free Cash Flow**Negative £30.3 million (H1 2024: Negative £31.2 million), with expectations of positive cash flow in H2.
**Net Debt to EBITDA Ratio**Increased to 4.8x (H1 2024: 4.6x), within covenant limits.
Synthomer remains focused on derisking its balance sheet, advancing its specialty strategy, and prioritizing sustainable growth opportunities.
Here is a comparison of Synthomer PLC's financials and debt year on year, presented as an HTML table:
MetricH1 2025H1 2024Change
Revenue (£m)925.21,025.6(9.8%)
EBITDA (£m)77.874.7+4.1%
EBITDA margin (%)8.4%7.3%+110bps
Underlying operating profit (£m)28.328.2+0.4%
Statutory operating loss (£m)(1.0)(2.9)+65.5%
Net debt (£m)638.3560.6+13.9%
Free Cash Flow (£m)(30.3)(31.2)+2.9%

Key Observations:

  • Revenue decreased by 9.8% year-on-year, primarily due to lower volumes and pass-through of lower raw material prices.
  • EBITDA increased by 4.1%, driven by self-help actions, including robust pricing and cost efficiency improvements.
  • Net debt increased by 13.9%, mainly due to seasonal cash flow patterns and capital expenditure phasing.
  • Free Cash Flow improved slightly, with expectations of positive Free Cash Flow in H2 2025.
**Note:** The percentages in the "Change" column are calculated based on the provided data. The table provides a concise comparison of key financial metrics and debt levels between H1 2025 and H1 2024.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 3
SYNT 10:58
Synthomer plc
Director/PDMR Shareholding
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of ordinary shares of 1 pence each in Synthomer plc
SYNT 10:01
Synthomer plc
Directorate Change
SYNT 06:01
Synthomer plc
Interim results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Synthomer PLC Interim Results for H1 2025**
Synthomer PLC, a leading supplier of specialized polymers and ingredients, reported its interim results for the six months ended June 30, 2025, highlighting continued earnings growth despite subdued market conditions. Key points from the report include
### **Financial Performance**
**Revenue**Declined by 9.8% to £925.2 million (H1 2024: £1,025.6 million), with a constant currency decline of 8.8%, primarily due to lower volumes and raw material price pass-throughs.
**EBITDA**Increased by 4.1% to £77.8 million (H1 2024: £74.7 million), with a constant currency growth of 5.4%, driven by self-help actions and cost efficiencies.
**EBITDA Margin**Improved to 8.4% from 7.3% in H1 2024, reflecting better cost management.
**Underlying Operating Profit (EBIT)**Rose slightly by 0.4% to £28.3 million (H1 2024: £28.2 million).
**Statutory Operating Loss (EBIT)**Narrowed to £1.0 million (H1 2024: £2.9 million loss).
**Net Debt**Increased to £638.3 million (H1 2024: £560.6 million) due to seasonal cash flow patterns and capital expenditure.
### **Divisional Performance**
**Coatings & Construction Solutions (CCS)**: Revenue declined by 13.5% to £372.5 million, with EBITDA down 34.9% to £34.5 million, impacted by lower oil and gas drilling activity.
**Adhesive Solutions (AS)**Revenue decreased by 3.3% to £298.4 million, but EBITDA surged by 61.6% to £35.4 million, driven by cost efficiency and reliability improvements.
**Health & Protection and Performance Materials (HPPM)**: Revenue fell by 11.2% to £254.3 million, with EBITDA up 23.0% to £16.6 million, benefiting from favorable mix and cost reductions.
### **Strategic Initiatives**
**Portfolio Transformation**Completed the divestment of William Blythe in May 2025, reducing the global manufacturing footprint to <mark style="background-color:yellow">below</mark> 30 sites (from 43 in 2022).
**Cost Reduction**Implemented a £20-25 million cost reduction program, expected to deliver £9 million in benefits in H2 2025.
**Innovation**Launched new specialty adhesive investments in the US and expanded partnerships for medical glove technology.
### **Market Conditions**
**Tariff Impact**Limited direct exposure to new tariffs, but increased customer demand volatility in Q2, improving in June.
**End-Market Demand**Subdued due to trade tensions, with volumes down 7.1% compared to H1 2024.
### **Outlook**
**2025 Expectations**Some earnings progress and broadly neutral Free Cash Flow, supported by self-help actions and strategic benefits.
**Medium-Term Goal**Aim to double recent earnings levels through self-help, volume recovery, and strategic execution.
### **CEO Commentary**
CEO Michael Willome emphasized the company’s resilience in challenging markets, highlighting the success of self-help actions and strategic portfolio adjustments. He reaffirmed confidence in achieving medium-term earnings growth despite near-term uncertainties.
### **Key Metrics**
**Free Cash Flow**Negative £30.3 million (H1 2024: Negative £31.2 million), with expectations of positive cash flow in H2.
**Net Debt to EBITDA Ratio**Increased to 4.8x (H1 2024: 4.6x), within covenant limits.
Synthomer remains focused on derisking its balance sheet, advancing its specialty strategy, and prioritizing sustainable growth opportunities.
Here is a comparison of Synthomer PLC's financials and debt year on year, presented as an HTML table:
MetricH1 2025H1 2024Change
Revenue (£m)925.21,025.6(9.8%)
EBITDA (£m)77.874.7+4.1%
EBITDA margin (%)8.4%7.3%+110bps
Underlying operating profit (£m)28.328.2+0.4%
Statutory operating loss (£m)(1.0)(2.9)+65.5%
Net debt (£m)638.3560.6+13.9%
Free Cash Flow (£m)(30.3)(31.2)+2.9%

Key Observations:

  • Revenue decreased by 9.8% year-on-year, primarily due to lower volumes and pass-through of lower raw material prices.
  • EBITDA increased by 4.1%, driven by self-help actions, including robust pricing and cost efficiency improvements.
  • Net debt increased by 13.9%, mainly due to seasonal cash flow patterns and capital expenditure phasing.
  • Free Cash Flow improved slightly, with expectations of positive Free Cash Flow in H2 2025.
**Note:** The percentages in the "Change" column are calculated based on the provided data. The table provides a concise comparison of key financial metrics and debt levels between H1 2025 and H1 2024.

Today's AI

Today's AI Starts With News

3 live catalysts is opening Today’s AI for SYNT.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2025-08-05 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
3 Today
Front Of Desk
Synthomer plc has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
10:01 Today's Catalyst Directorate Change
Single-Ticker Today's AI
SYNT signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Synthomer plc. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full SYNT Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for SYNT on 2025-08-05.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
183.6M
Enterprise Value
1.8B
Public Float
72.1
Broker Target
142.714
Shares Out
163.9M
Long Interest
92
Short Interest
8
Exchange
LSE
Currency Code
GBX
ISIN
GB00BNTVWJ75
Market
LSE - MAIN MARKET
Sector
Chemicals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

3 live alerts now opens the financials desk for SYNT.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2025-08-05 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
3 Alerts
Front Of Desk
Synthomer plc has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
10:01 Today's Alert Directorate Change
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2022-10-06
Earnings Date
2026-04-30
Net Debt
628.6M
Cash
189.9M
EPS
-0.92
Net Income
-157.0M
Revenue
1.7B
Enterprise Value
1.8B
Trailing PE
-
Forward PE
21.7391
Price Sales TTM
0.1056
Price Book MRQ
0.198
EV Revenue
0.464
EV EBITDA
14.9716
Financial Forecastist

Mixed financial engine

Revenue is slipping -9.1% against the prior comparable period. Net margin is compressing by 8.0 pts. Net debt is building +13.3%.

Revenue -9.1% Net Income +110.0% FCF +47.5% Current Ratio 1.57x Forward Rev 0
Mixed
Quarter Revenue
814.0M
-9.1%
vs prior comparable quarter
Net Margin
-14.2%
-8.0 pts
profitability pulse
Free Cash Flow
77.0M
+47.5%
cash conversion
Net Debt / EBITDA
8.4x
+13.3%
lower is cleaner
Revenue Engine

Latest quarter printed 814.0M with the top line cooling off against the last comparable period.

Profit Stack

Net income landed at -115.3M and the margin profile is tightening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 189.9M while net debt is 628.6M. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q2 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q1 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
1.9B
Revenue Path
-0.08
EPS / Earnings
Growth cue +0.8%
FY 2027
Consensus
2.0B
Revenue Path
0.09
EPS / Earnings
Growth cue +2.1%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 814.0M -115.3M 77.0M 628.6M
Q2 2025 925.2M -41.7M -40.4M 694.2M
Q4 2024 935.7M -41.9M -42.3M 652.9M
Q2 2024 1.1B -30.7M -81.8M 609.4M
Q4 2023 895.6M -54.9M 52.2M 555.0M
Q2 2023 1.1B -12.1M 15.7M 853.9M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 1.7B -157.0M 137.0M 36.6M
FY 2024 2.0B -72.6M 83.0M -124.1M
FY 2023 2.0B -67.0M 113.4M 66.0M
FY 2022 2.3B -32.5M 139.4M 43.1M
FY 2021 2.1B 208.7M 394.4M 191.3M

Structure DNA

Market Structure DNA

Balanced Structure profile with trend broken

Price is -10.3% through the 52-week range, -81.3% vs 50DMA and -89.9% vs 200DMA. 71.8% of the register is locked by institutions and insiders, leaving 28.2% free float. Capital rhythm reads semi-annual with forward yield near 0.0% and payout around 0.0%.

Trend broken Institutional gravity Moderate income rhythm As Of 2026-04-19
Balanced Structure
Structure Score
44.3 / 100
Balanced Structure
Trend Stack
-81.3% / -89.9%
vs 50DMA / 200DMA
52W Position
-10.3%
auction position inside the yearly range
Ownership Lock
71.8%
43.8% institutions | 27.9% insiders
Pressure Pocket
1.5% short float
Short ratio 0.0x | monthly -
Capital Rhythm
Semi-Annual
Yield 0.0% | payout 0.0%
Trend Runway

Implied spot is 5.63 with the stock -81.3% vs 50DMA and -89.9% vs 200DMA. The tape is sitting -10.3% through the 52-week range, which frames the regime as trend broken.

Ownership Register

Institutions hold about 43.8% and insiders about 27.9%, locking roughly 71.8% of the register and leaving 28.2% in free float. That reads as institutional gravity.

Pressure Pocket

Short pressure is running near 1.5% of float with short ratio 0.0x and monthly change -. That gives us a read on whether the tape is clean, crowded, or coiled.

Capital Rhythm

Dividend cadence reads semi-annual with 3 event(s) in the last full year, a five-year average of 2.4, and stability score 60.0/100. Forward yield sits near 0.0% while payout is around 0.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Semi-Annual
Year Dividend Count Context
2022 3 Full year
2021 3 Full year
2020 2 Full year
2019 2 Full year
2018 2 Full year
2017 2 Full year
2016 2 Full year
2015 2 Full year

Structure Facts

Live Snapshot
Implied Spot
5.63
derived from market cap / shares
52W High
123.74
upper auction edge
52W Low
16.70
lower auction edge
Beta
0.56
volatility character
Shares Out
163.5M
fully diluted count
Shares Float
118.6M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
2022-10-06
-1291 day(s) to ex-date
Dividend Pay
-
payment date not supplied
Last Split
1:20
2023-09-26

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
19.426
Institutions As Of
2026-05-05
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
5
Sale Director Dealing
0
Purchase TR1
5
Sale TR1
6
Broker Coverage Rows
18
Institution Holders Tracked
4
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for SYNT, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2025-08-05 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
3 Today
Catalyst Pulse
Synthomer plc has fresh news flow live now, so the tape is framing the chart workspace below.
10:01 Today's Catalyst Directorate Change
AI Charts Studio
SYNT Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-08-05 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast 93.48%
RSI Gauge
Price Change
AI Forecast